Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,189 | 399 | 97.1% |
| Education | $187.19 | 3 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,174 | 87 | $0 (2024) |
| PFIZER INC. | $632.57 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $437.76 | 28 | $0 (2024) |
| Amgen Inc. | $425.95 | 32 | $0 (2024) |
| Novo Nordisk Inc | $377.94 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $316.56 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $271.54 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $256.44 | 15 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $249.90 | 14 | $0 (2024) |
| Dexcom, Inc. | $165.59 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,094 | 126 | ABBVIE INC. ($370.55) |
| 2023 | $1,664 | 98 | AbbVie Inc. ($459.86) |
| 2022 | $1,025 | 68 | ABBVIE INC. ($190.37) |
| 2021 | $994.74 | 69 | AbbVie Inc. ($153.34) |
| 2020 | $291.03 | 19 | Amarin Pharma Inc. ($59.23) |
| 2019 | $306.97 | 22 | AstraZeneca Pharmaceuticals LP ($63.83) |
All Payment Transactions
402 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Inari Medical, Inc. | CT THROMBECTOMY SYSTEM KIT (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: VTE | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Biological | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: PAIN | ||||||
| 11/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,451 | 2,335 | $439,080 | $119,301 |
| 2022 | 19 | 1,486 | 2,441 | $410,943 | $115,065 |
| 2021 | 21 | 1,546 | 2,607 | $430,403 | $129,072 |
| 2020 | 20 | 1,547 | 2,525 | $377,386 | $105,591 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 379 | 715 | $221,565 | $56,298 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 275 | 275 | $126,736 | $33,431 | 26.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 34 | 34 | $31,246 | $9,301 | 29.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 91 | 91 | $12,012 | $6,801 | 56.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 382 | 788 | $17,549 | $6,484 | 36.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 99 | 99 | $3,960 | $2,864 | 72.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 26 | $5,288 | $1,241 | 23.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 34 | 34 | $1,360 | $954.69 | 70.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 88 | $5,079 | $766.51 | 15.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 15 | $3,486 | $553.55 | 15.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 19 | $2,669 | $175.36 | 6.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 13 | 14 | $3,464 | $136.32 | 3.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 15 | 22 | $1,894 | $124.31 | 6.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 35 | 103 | $1,545 | $95.20 | 6.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 11 | 12 | $1,227 | $73.24 | 6.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 372 | 721 | $212,361 | $59,514 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 256 | 256 | $112,198 | $31,680 | 28.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 82 | 82 | $10,824 | $5,761 | 53.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $16,542 | $5,005 | 30.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 100 | 100 | $4,000 | $2,753 | 68.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 432 | 828 | $17,581 | $2,421 | 13.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 12 | $7,581 | $1,848 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $5,781 | $1,564 | 27.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,400 | $939.88 | 67.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 28 | 28 | $1,120 | $773.92 | 69.1% |
About David Cykert
David Cykert is a Internal Medicine healthcare provider based in Spartanburg, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2016. The National Provider Identifier (NPI) number assigned to this provider is 1154777456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Cykert has received a total of $6,376 in payments from pharmaceutical and medical device companies, with $2,094 received in 2024. These payments were reported across 402 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($6,189).
As a Medicare-enrolled provider, Cykert has provided services to 6,030 Medicare beneficiaries, totaling 9,908 services with total Medicare billing of $469,029. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Spartanburg, SC
- Active Since 05/05/2016
- Last Updated 03/05/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1154777456
Products in Payments
- NURTEC ODT (Drug) $353.84
- UBRELVY (Drug) $337.02
- FARXIGA (Drug) $324.16
- VRAYLAR (Drug) $209.15
- QULIPTA (Drug) $200.62
- Ozempic (Drug) $199.49
- LINZESS (Drug) $193.03
- LEQVIO (Drug) $168.09
- Otezla (Drug) $167.51
- GEMTESA (Drug) $164.53
- Vascepa (Drug) $161.49
- ELIQUIS (Drug) $159.08
- TRINTELLIX (Drug) $157.02
- TRELEGY ELLIPTA (Drug) $148.04
- JARDIANCE (Drug) $137.84
- Dexcom G6 Transmitter (Medical Supply) $134.65
- EVENITY (Biological) $134.56
- FLOWTRIEVER CATHETER, S (Device) $116.69
- Aimovig (Biological) $113.45
- INJECTAFER (Drug) $113.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Spartanburg
Dr. Vikas Dembla, M.d, M.D
Internal Medicine — Payments: $548,574
Dr. Tondre Buck, M.d, M.D
Internal Medicine — Payments: $390,444
Michael Humeniuk, Md, MD
Internal Medicine — Payments: $28,166
Suzanne Kovacs, Md, MD
Internal Medicine — Payments: $16,168
Dr. Ikenna Onyebueke, Md, MD
Internal Medicine — Payments: $13,555
Dr. Subhashini Subramaniam, Md, MD
Internal Medicine — Payments: $13,395